FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2031053334> ?p ?o ?g. }

• W2031053334 endingPage "213" @default.
• W2031053334 startingPage "207" @default.
• W2031053334 abstract "To assess the antihypertensive and antiproteinuric efficacy and safety of the angiotensin II type 1 receptor blocker telmisartan in patients with hypertension and chronic kidney disease.A multicenter, prospective trial was performed in adults with hypertension [systolic blood pressure (SBP)/diastolic blood pressure (DBP) >130/85 mmHg), chronic renal insufficiency (serum creatinine <4.0 mg/dl), and proteinuria (>1 g/24 h). In addition to existing antihypertensive therapy, the nature and doses of which remained unchanged throughout the study, patients received once-daily telmisartan 40 mg for the first 3 months followed by forced titration to telmisartan 80 mg for the subsequent 3 months to achieve a target SBP/DBP of <130/85 mmHg. The rationale for using telmisartan was its long half-life efficacy, greater antihypertensive effect compared with valsartan or losartan, and newly discovered potential antidiabetic effect.The study was conducted in 92 patients (45 men, 47 women), of whom 60 had diabetes mellitus (54 patients with type 2 disease). Five patients discontinued prematurely: two because of hyperkalemia, two because of protocol violation, and one because of lack of efficacy. After 6 months' telmisartan treatment, office trough seated SBP was reduced by 19.6 mmHg (P<0.001) from 154.9+/-14.6 mmHg and DBP by 11.8 mmHg (P<0.001) from 91.7+/-8.1 mmHg. Seated trough SBP/DBP of <130/85 mmHg was achieved at 6 months in 34.8% of patients. Ambulatory blood pressure monitoring also demonstrated significant reductions in mean daytime SBP of 10.9 mmHg (P=0.01), night-time SBP of 12.1 mmHg (P=0.05), daytime DBP of 3.1 mmHg (P=0.05), and night-time DBP of 6.5 mmHg (P=0.05). Proteinuria decreased significantly from 3.6+/-3.4 to 2.8+/-2.8 g/24 h (P=0.01). A decrease in proteinuria depended significantly on a decrease in SBP at the end of the study (P=0.044). Each decrease in SBP of about 10 mmHg led to a decrease in proteinuria of about 0.79 g/24 h (95% CI 0.02-1.56 g/24 h). Serum creatinine increased from 1.96+/-0.79 to 2.08+/-0.89 mg/dl (P=0.01), whereas creatinine clearance did not change significantly.Telmisartan effectively and safely reduced blood pressure and brought about regression of proteinuria in diabetic and nondiabetic, hypertensive, proteinuric patients with chronic kidney disease, even in those with mild-to-moderate chronic renal failure." @default.
• W2031053334 created "2016-06-24" @default.
• W2031053334 creator A5016613978 @default.
• W2031053334 creator A5045895952 @default.
• W2031053334 creator A5081888215 @default.
• W2031053334 date "2005-08-01" @default.
• W2031053334 modified "2023-10-12" @default.
• W2031053334 title "Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease" @default.
• W2031053334 cites W1539206789 @default.
• W2031053334 cites W1966932663 @default.
• W2031053334 cites W1974802912 @default.
• W2031053334 cites W1983813619 @default.
• W2031053334 cites W1984061204 @default.
• W2031053334 cites W1991855816 @default.
• W2031053334 cites W1994174864 @default.
• W2031053334 cites W1995753814 @default.
• W2031053334 cites W1998358424 @default.
• W2031053334 cites W2031335602 @default.
• W2031053334 cites W2033244214 @default.
• W2031053334 cites W2036960544 @default.
• W2031053334 cites W2044773944 @default.
• W2031053334 cites W2051801861 @default.
• W2031053334 cites W2052769450 @default.
• W2031053334 cites W2056976690 @default.
• W2031053334 cites W2063090466 @default.
• W2031053334 cites W2071470712 @default.
• W2031053334 cites W2075525764 @default.
• W2031053334 cites W2080742733 @default.
• W2031053334 cites W2084343172 @default.
• W2031053334 cites W2090314376 @default.
• W2031053334 cites W2093767212 @default.
• W2031053334 cites W2118989562 @default.
• W2031053334 cites W2123015449 @default.
• W2031053334 cites W2143001953 @default.
• W2031053334 cites W2143144750 @default.
• W2031053334 cites W2144709736 @default.
• W2031053334 cites W2312201455 @default.
• W2031053334 cites W2312400976 @default.
• W2031053334 cites W2615684303 @default.
• W2031053334 cites W3021250193 @default.
• W2031053334 cites W3156148333 @default.
• W2031053334 doi "https://doi.org/10.1097/01.mbp.0000172708.97534.15" @default.
• W2031053334 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16077267" @default.
• W2031053334 hasPublicationYear "2005" @default.
• W2031053334 type Work @default.
• W2031053334 sameAs 2031053334 @default.
• W2031053334 citedByCount "21" @default.
• W2031053334 countsByYear W20310533342012 @default.
• W2031053334 countsByYear W20310533342016 @default.
• W2031053334 countsByYear W20310533342017 @default.
• W2031053334 countsByYear W20310533342019 @default.
• W2031053334 countsByYear W20310533342020 @default.
• W2031053334 countsByYear W20310533342022 @default.
• W2031053334 crossrefType "journal-article" @default.
• W2031053334 hasAuthorship W2031053334A5016613978 @default.
• W2031053334 hasAuthorship W2031053334A5045895952 @default.
• W2031053334 hasAuthorship W2031053334A5081888215 @default.
• W2031053334 hasConcept C104849204 @default.
• W2031053334 hasConcept C126322002 @default.
• W2031053334 hasConcept C126894567 @default.
• W2031053334 hasConcept C134018914 @default.
• W2031053334 hasConcept C149323552 @default.
• W2031053334 hasConcept C159641895 @default.
• W2031053334 hasConcept C164705383 @default.
• W2031053334 hasConcept C2778653478 @default.
• W2031053334 hasConcept C2779561371 @default.
• W2031053334 hasConcept C2779716603 @default.
• W2031053334 hasConcept C2780091579 @default.
• W2031053334 hasConcept C2780288358 @default.
• W2031053334 hasConcept C2908929049 @default.
• W2031053334 hasConcept C71924100 @default.
• W2031053334 hasConcept C84393581 @default.
• W2031053334 hasConceptScore W2031053334C104849204 @default.
• W2031053334 hasConceptScore W2031053334C126322002 @default.
• W2031053334 hasConceptScore W2031053334C126894567 @default.
• W2031053334 hasConceptScore W2031053334C134018914 @default.
• W2031053334 hasConceptScore W2031053334C149323552 @default.
• W2031053334 hasConceptScore W2031053334C159641895 @default.
• W2031053334 hasConceptScore W2031053334C164705383 @default.
• W2031053334 hasConceptScore W2031053334C2778653478 @default.
• W2031053334 hasConceptScore W2031053334C2779561371 @default.
• W2031053334 hasConceptScore W2031053334C2779716603 @default.
• W2031053334 hasConceptScore W2031053334C2780091579 @default.
• W2031053334 hasConceptScore W2031053334C2780288358 @default.
• W2031053334 hasConceptScore W2031053334C2908929049 @default.
• W2031053334 hasConceptScore W2031053334C71924100 @default.
• W2031053334 hasConceptScore W2031053334C84393581 @default.
• W2031053334 hasIssue "4" @default.
• W2031053334 hasLocation W20310533341 @default.
• W2031053334 hasLocation W20310533342 @default.
• W2031053334 hasOpenAccess W2031053334 @default.
• W2031053334 hasPrimaryLocation W20310533341 @default.
• W2031053334 hasRelatedWork W1975305402 @default.
• W2031053334 hasRelatedWork W2024666042 @default.
• W2031053334 hasRelatedWork W2031658817 @default.
• W2031053334 hasRelatedWork W2034361879 @default.
• W2031053334 hasRelatedWork W2078095631 @default.
• W2031053334 hasRelatedWork W2130732372 @default.

• next